Improved Clinical and Microscopy Diagnosis at Primary Health Care in Tanzania
NCT ID: NCT00687895
Last Updated: 2008-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
3131 participants
INTERVENTIONAL
2003-07-31
2004-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All children attending the 16 PHC facilities under the study during daytime were enrolled if they fulfilled the following criteria:
1. below five years of age
2. fever (temperature≥37.5◦C) and/or reported history of fever in last 2 days
3. able to return to the facility on day 7 after treatment or any other day if symptoms were to worsen or recur
4. the mother/guardian or caretaker consented to participate.
Patients with severe disease and/or general danger signs requiring inpatient care according to the IMCI guidelines were admitted or referred to the health centers or the district hospitals
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
training in clinical algorithm plus microscopy
Clinical algorithm and microscopy diagnosis of malaria
Clinical alogarithm
The content of the package included
1. description of signs and symptoms of malaria disease
2. history taking relevant to malaria and physical examination
3. identification of danger signs and severe illness for referral
4. appropriate treatment
5. counseling patients on the use of drugs.
Malaria microscopy. contents
1. make thick blood smears from patients with fever and stain with Giemsa
2. identify and count malaria parasites
3. maintain the microscope and store blood slides.
2
clinical algorithm
Clinical algorithm and microscopy diagnosis of malaria
Clinical alogarithm
The content of the package included
1. description of signs and symptoms of malaria disease
2. history taking relevant to malaria and physical examination
3. identification of danger signs and severe illness for referral
4. appropriate treatment
5. counseling patients on the use of drugs.
Malaria microscopy. contents
1. make thick blood smears from patients with fever and stain with Giemsa
2. identify and count malaria parasites
3. maintain the microscope and store blood slides.
3
Control
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical algorithm and microscopy diagnosis of malaria
Clinical alogarithm
The content of the package included
1. description of signs and symptoms of malaria disease
2. history taking relevant to malaria and physical examination
3. identification of danger signs and severe illness for referral
4. appropriate treatment
5. counseling patients on the use of drugs.
Malaria microscopy. contents
1. make thick blood smears from patients with fever and stain with Giemsa
2. identify and count malaria parasites
3. maintain the microscope and store blood slides.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. fever (temperature≥37.5◦C) and/or reported history of fever in last 2 days
3. able to return to the facility on day 7 after treatment or any other day if symptoms were to worsen or recur
4. the mother/guardian or caretaker consented to participate
Exclusion Criteria
6 Months
59 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Muhimbili University of Health and Allied Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhimbili University College of Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anders Bjorkman, MD
Role: STUDY_DIRECTOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
dispensaries/health centers in Kibaha and Bagamoyo
Coast, Coast Region, Tanzania
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bates I, Bekoe V, Asamoa-Adu A. Improving the accuracy of malaria-related laboratory tests in Ghana. Malar J. 2004 Nov 1;3:38. doi: 10.1186/1475-2875-3-38.
Ngasala B, Mubi M, Warsame M, Petzold MG, Massele AY, Gustafsson LL, Tomson G, Premji Z, Bjorkman A. Impact of training in clinical and microscopy diagnosis of childhood malaria on antimalarial drug prescription and health outcome at primary health care level in Tanzania: a randomized controlled trial. Malar J. 2008 Oct 2;7:199. doi: 10.1186/1475-2875-7-199.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HF2003
Identifier Type: -
Identifier Source: org_study_id